Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Herpes Infections Global Clinical Trials Review, H2, 2014

Published: Nov-2014 | Format: PDF | GlobalData | Number of pages: 128 | Code: MRS - 2048

 

GlobalData's clinical trial report, “Herpes Infections Global Clinical Trials Review, H2, 2014"" provides data on the Herpes Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Herpes Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Herpes Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

 

Scope

 

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)

 

Reasons to buy

 

Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
 

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Herpes Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Herpes Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Herpes Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Herpes Infections 25
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Herpes Infections Therapeutics Clinical Trials 34
Prominent Drugs 35
Latest Clinical Trials News on Herpes Infections 36
Oct 08, 2014: NanoBio To Present Data Demonstrating The Potential For Its Intranasal Vaccine To Protect Against Genital Herpes Infection 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
Merck & Co., Inc. 44
Clinical Trial Overview of Merck & Co., Inc. 44
F. Hoffmann-La Roche Ltd. 48
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 48
Novartis AG 52
Clinical Trial Overview of Novartis AG 52
Astellas Pharma Inc. 54
Clinical Trial Overview of Astellas Pharma Inc. 54
Sanofi 55
Clinical Trial Overview of Sanofi 55
Pfizer Inc. 56
Clinical Trial Overview of Pfizer Inc. 56
AstraZeneca PLC 57
Clinical Trial Overview of AstraZeneca PLC 57
Vical Incorporated 59
Clinical Trial Overview of Vical Incorporated 59
Gilead Sciences, Inc. 60
Clinical Trial Overview of Gilead Sciences, Inc. 60
Clinical Trial Overview of Top Institutes / Government 61
The National Institute of Allergy and Infectious Diseases 61
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 61
National Cancer Institute 66
Clinical Trial Overview of National Cancer Institute 66
University of Washington 68
Clinical Trial Overview of University of Washington 68
National Heart, Lung, and Blood Institute 69
Clinical Trial Overview of National Heart, Lung, and Blood Institute 69
National Center for Research Resources 70
Clinical Trial Overview of National Center for Research Resources 70
National Eye Institute 71
Clinical Trial Overview of National Eye Institute 71
Baylor College of Medicine 72
Clinical Trial Overview of Baylor College of Medicine 72
University of California, San Francisco 73
Clinical Trial Overview of University of California, San Francisco 73
University of Alabama at Birmingham 74
Clinical Trial Overview of University of Alabama at Birmingham 74
Memorial Sloan Kettering Cancer Center 75
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 75
Five Key Clinical Profiles 76

Appendix 126
Abbreviations 126
Definitions 126
Research Methodology 127
Secondary Research 127
About GlobalData 128
Contact Us 128
Disclaimer 128
Source 128

 

List of Tables
 

Herpes Infections Therapeutics, Global, Clinical Trials by Region, 2014* 7
Herpes Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Herpes Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Herpes Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Herpes Infections Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Herpes Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Herpes Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Herpes Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Herpes Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Herpes Infections Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Herpes Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Herpes Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Herpes Infections Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Herpes Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Herpes Infections Therapeutics, Global, Terminated Clinical Trials, 2014* 28
Herpes Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 31
Herpes Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 32
Herpes Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 33
Herpes Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 34
Herpes Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 35
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 37
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 44
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 48
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 52
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 54
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 55
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 56
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 57
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Vical Incorporated, 2014* 59
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 60
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 61
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 66
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 68
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 69
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 70
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014* 71
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2014* 72
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 73
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2014* 74
Herpes Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 75
 

List of Figures

 

Herpes Infections Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Herpes Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Herpes Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Herpes Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Herpes Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Herpes Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Herpes Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Herpes Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Herpes Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Herpes Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Herpes Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Herpes Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Herpes Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Herpes Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Herpes Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Herpes Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 31
Herpes Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 32
Herpes Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 33
Herpes Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 34
Herpes Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 35
GlobalData Methodology 127

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing